Biofrontera AG BFFTF
Set alert
0.33 +0.33 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 19.35M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- —
- High
- —
Financial health
Altman Z-Score
-7.46 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.0×
FY 2019 5y median -0.2× FY 2023
P/S 0.0×
FY 2019 5y median 0.1× FY 2023
P/B 0.1×
FY 2019 5y median 0.1× FY 2023
P/FCF -0.0×
FY 2019 5y median -0.1× FY 2023
EV/EBITDA -0.3×
FY 2019 5y median -0.3× FY 2023
EV/Sales 0.2×
FY 2019 5y median -0.3× FY 2023
FCF Yield -4879.7%
FY 2019 5y median -1143.7% FY 2023
Profitability
Gross Margin 48.8%
FY 2019 5y median 48.8% FY 2023
Operating Margin -66.6%
FY 2019 5y median -66.6% FY 2023
Net Margin -59.1%
FY 2019 5y median -58.3% FY 2023
ROE -420.0%
FY 2019 5y median -188.5% FY 2023
ROIC -149.9%
FY 2019 5y median -72.2% FY 2023
ROA -72.1%
FY 2019 5y median -45.5% FY 2023
Growth (YoY)
Revenue 18.8%
FY 2019 FY 2023
Operating Income -1.3%
FY 2019 FY 2023
EPS (diluted) -2034.4%
FY 2019 FY 2023
Free Cash Flow -53.4%
FY 2019 FY 2023
Financial Health
Current Ratio 1.3×
FY 2019 5y median 2.1× FY 2023
Quick Ratio 0.7×
FY 2019 5y median 1.7× FY 2023
Debt / Equity 1.3×
FY 2019 5y median 0.0× FY 2023
Net Debt / EBITDA -0.3×
FY 2019 5y median -0.3× FY 2023
Interest Coverage -37.8×
FY 2019 5y median -37.8× FY 2023
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2023
Annual · latest fiscal year ends 2023-12-31